Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11532686 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Conditions: Chronic Kidney Disease;   Cardiovascular Disease
Interventions: Drug: Spironolactone;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.